Brexpiprazole augmentation in a clozapine-resistant young schizophrenic patient: a successful case report.

INTRODUCTION: Although clozapine is considered the most effective drug for Treatment Resistant Schizophrenia (TRS), only 40% of patients treated will meet clinical response. Literature reviews and meta-analytic data offer no definite conclusions about the most effective clozapine augmentation strate...

Descripción completa

Detalles Bibliográficos
Autores principales: Martiadis, V., Raffone, F., Russo, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478854/
http://dx.doi.org/10.1192/j.eurpsy.2023.2317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478854/
http://dx.doi.org/10.1192/j.eurpsy.2023.2317

Ejemplares similares